Geron Corp. GERN

NAS: GERN | ISIN: US3741631036 22/09/2026

1,310 USD (+0,77%)

(+0,77%) 22/09/2026

Grafiek Geron Corp.

Grafiek Geron Corp.

1 dag1d 0,77%
1 week1w 1,55%
1 maand1m -13,82%
3 maanden3m -2,96%
6 maanden6m -14,94%
1 jaar1j -2,24%
5 jaar5j -9,66%

Geron Corp. in het nieuws

Toon enkel gratis nieuws

2 september 2026 · Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? · Persbericht

3 maart 2026 · Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone · Persbericht

4 december 2025 · Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points · Persbericht

9 mei 2025 · Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation(GERN) · Persbericht

6 mei 2025 · INVESTOR DEADLINE NEXT WEEK: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GERN · Persbericht

6 mei 2025 · Geron Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 12, 2025 to Discuss Your Rights - GERN · Persbericht

2 mei 2025 · Levi & Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN · Persbericht

27 april 2025 · Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN · Persbericht

26 april 2025 · GERN INVESTOR NOTICE: Geron Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit · Persbericht

25 april 2025 · Investors who lost money on Geron Corporation(GERN) should contact Levi & Korsinsky about pending Class Action - GERN · Persbericht

Profiel Geron Corp.

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.geron.com

Hoofdzetel: Foster City, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe